Related references
Note: Only part of the references are listed.Pathogenesis of myeloproliferative neoplasms
Radek C. Skoda et al.
EXPERIMENTAL HEMATOLOGY (2015)
The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm
Veena Sangkhae et al.
BLOOD (2014)
Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation
Jean-Philippe Defour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MPL Mutation Profile in JAK2 Mutation-negative Patients With Myeloproliferative Disorders
Wanlong Ma et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2011)
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients
A. Pardanani et al.
LEUKEMIA (2011)
CYSTM, a novel cysteine-rich transmembrane module with a role in stress tolerance across eukaryotes
Thiago M. Venancio et al.
BIOINFORMATICS (2010)
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor
Christian Pecquet et al.
BLOOD (2010)
Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis
Elaine M. Boyd et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
MPL mutations in myeloproliferative disorders:: analysis of the PT-1 cohort
Philip A. Beer et al.
BLOOD (2008)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor
J Staerk et al.
BLOOD (2006)
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
F Ding et al.
BLOOD (2004)
A novel MPL point mutation resulting in thrombopoietin-independent activation
M Abe et al.
LEUKEMIA (2002)
Share Paper
